Enveric Biosciences
ENVB
ENVB
30 hedge funds and large institutions have $3.61M invested in Enveric Biosciences in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
19% less capital invested
Capital invested by funds: $4.45M → $3.61M (-$831K)
Holders
30
Holding in Top 10
–
Calls
$78K
Puts
$10K
Top Buyers
| 1 | +$1.58M | |
| 2 | +$474K | |
| 3 | +$205K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$51.3K |
| 5 |
VF
Virtu Financial
New York
|
+$44.5K |
Top Sellers
| 1 | -$690K | |
| 2 | -$55K | |
| 3 | -$39K | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$35.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$33.1K |